Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults
Clinical trial NCT03942406 · COMPLETED
Trial details
- NCT number
- NCT03942406
- Sponsor
- ILiAD Biotechnologies
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-15
- Primary completion
- 2020-02-14
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.